Breast Ultrasound Market by Product (Accessories & Consumables, Equipment, Services), Modality (Cart/Trolley, Handheld), Technology, Transducer Type, Application, End User - Global Forecast 2025-2032
Description
The Breast Ultrasound Market was valued at USD 3.19 billion in 2024 and is projected to grow to USD 3.54 billion in 2025, with a CAGR of 10.96%, reaching USD 7.33 billion by 2032.
An integrative orientation on breast ultrasound trends and clinical priorities designed to align device innovation with real-world diagnostic and interventional workflows
This executive summary synthesizes the current strategic dynamics and operational considerations shaping breast ultrasound across clinical, commercial, and supply chain domains. The report distills emerging technology trends, modality preferences, and user requirements that are influencing procurement choices and technology roadmaps in diagnostic and interventional care pathways. By concentrating on practical implications rather than projections, the analysis highlights how clinical workflows, device ergonomics, and service models are converging to elevate diagnostic confidence and procedural efficiency.
Stakeholders in clinical leadership, procurement, and product development will find a structured view of the evolving competitive ecosystem and the levers that affect adoption. The emphasis is on translating clinical need into device specification and on understanding how product portfolios of probes, systems, and consumables must adapt to changing practice patterns. The introductory narrative establishes the analytical lens for the remainder of the document: an operator- and patient-centric approach that aligns technology attributes with real-world clinical and operational constraints, enabling clearer priorities for investment and partnership.
How advances in imaging resolution, portable modalities, and service-driven commercial models are reshaping procurement priorities and clinical workflows in breast ultrasound
The breast imaging landscape is experiencing transformative shifts driven by a combination of technological maturation, workflow reconfiguration, and evolving clinical expectations. Advances in image resolution and elastography algorithms are enhancing lesion characterization capabilities, which in turn is changing how clinicians prioritize investments across systems, probes, and accessory suites. Simultaneously, the movement toward more portable and bedside diagnostics is accelerating the adoption of cart-based portable systems and handheld devices that can be integrated into outpatient clinics and ambulatory settings, reshaping traditional radiology-centric models.
Concurrently, service delivery models are shifting from pure transactional maintenance agreements toward outcome-oriented service partnerships that emphasize uptime, training, and remote diagnostics. Vendors that couple robust training programs with digital support and predictive maintenance features are gaining preference among health systems focused on continuity of care and operational efficiency. The combination of technological refinement and service innovation is therefore creating new competitive differentiation points tied to integration, ease of use, and the degree to which devices support multi-operator environments and interventional procedures.
Assessment of the 2025 US tariff adjustments and their operational consequences on sourcing, lead times, and procurement strategies for breast ultrasound ecosystems
Recent tariff measures instituted by the United States in 2025 have introduced new variables into supply chain planning and procurement for breast ultrasound equipment and accessories. Increased import duties on certain categories of medical equipment have prompted procurement teams to reassess supplier selection criteria, with emphasis placed on tariff classification expertise, alternative sourcing strategies, and the total landed cost of devices and consumables. These trade policy changes have also underscored the importance of contract flexibility, allowing buyers to negotiate terms that can mitigate sudden cost escalations and avoid disruptions to clinical operations.
Operationally, tariffs have lengthened lead times where manufacturers rely on cross-border components and finished goods, increasing the value of local inventory buffers and reinforcing partnerships with regional distributors. Manufacturers and providers have responded by intensifying efforts in tariff engineering-revising product bill of materials and HS code classifications where appropriate-and by expanding nearshoring and third-country sourcing options. The ripple effects extend to service and consumables, where items such as gel and sterile covers may be procured from different geographies to manage exposure. Ultimately, tariffs have elevated procurement sophistication and compelled both vendors and health systems to adopt a more proactive stance on trade compliance, supply redundancy, and scenario planning to sustain access to critical breast imaging capabilities.
Comprehensive segmentation analysis linking product types, modalities, technologies, transducer options, clinical applications, and end-user requirements to purchasing and adoption behaviors
Insight into segmentation reveals how product form, delivery modality, imaging technology, transducer design, clinical application, and end-user context each create distinct value propositions and adoption pathways. When the market is viewed by product, accessories and consumables such as gel and sterile covers represent recurring operational expenditures that must align with infection control protocols and operator ergonomics, while equipment encompassing probes and systems anchors capital planning and clinical capability. Services spanning installation, maintenance, and training are essential to ensure uptime and to translate advanced imaging features into reproducible clinical outcomes, and the interplay between these elements often dictates procurement cadence and vendor selection.
Considering modality, the differentiation between cart/trolley configurations and handheld formats informs deployment strategy: portable cart solutions, whether truly portable or trolley-mounted, are frequently chosen for centralized diagnostic suites, whereas battery-powered and tethered handheld devices enable point-of-care access in clinics and ambulatory surgical centers. Technology choices-ranging from 2D and 3D/4D ultrasound through Doppler and elastography-determine diagnostic scope and the types of clinical questions that can be addressed at the point of care, influencing both training needs and interpretation workflows. Transducer type matters for lesion accessibility and imaging fidelity; linear array, curved array, phased array, and emerging 3D transducers each offer trade-offs in field of view, resolution, and ergonomics, guiding procurement for specific clinical protocols.
From an application standpoint, diagnostic use cases such as lesion characterization, screening, and staging require consistent high-resolution imaging and reproducibility, while interventional tasks including aspiration, biopsy guidance, and drainage prioritize real-time visualization, probe handling, and sterile accessory compatibility. End-user considerations further refine segmentation: ambulatory surgical centers and clinics demand compact and easy-to-service systems with fast startup and minimal space footprint, diagnostic imaging centers emphasize multi-modality integration and advanced post-processing, and hospitals balance high-throughput scanning, diverse clinical teams, and comprehensive service agreements. The confluence of these segmentation dimensions underscores that a one-size-fits-all offering is unlikely to achieve broad adoption; instead, modularity, serviceability, and clinical fit are decisive.
Regional differentiation in adoption, regulatory context, and supply chain resilience shaping modality preferences and procurement strategies across global markets
Regional dynamics demonstrate distinct patterns of adoption, reimbursement influences, and supply chain strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, health systems and outpatient networks emphasize rapid integration of portable systems to expand access across decentralized care settings, and there is pronounced attention to purchasing practices that prioritize service continuity and interoperability with existing radiology workflows. In contrast, Europe, Middle East & Africa presents a heterogeneous set of adoption drivers, where regulatory harmonization in some subregions and resource variability in others shape differentiated demand for basic imaging functionality versus advanced features like elastography and 3D imaging.
Asia-Pacific exhibits strong demand for scalable, cost-efficient solutions that can serve high-volume screening programs as well as growing interventional capabilities in tertiary centers. Across all regions, local regulatory requirements, reimbursement mechanisms, and clinical pathway preferences influence the mix of systems, handheld devices, and consumables that are prioritized by buyers. Moreover, regional supply chain resilience considerations and the presence of local manufacturing capacity or distribution partners significantly affect lead times and service models, prompting stakeholders to design procurement strategies that balance local responsiveness with access to specialized technologies and training resources.
Competitive patterns driven by integration of advanced imaging features with service-led differentiation and interoperable technologies to secure clinical adoption and retention
Competitive dynamics in the breast ultrasound landscape are shaped by firms that combine imaging performance with comprehensive service and training offerings. Leading vendors are investing in software-defined imaging enhancements, probe ergonomics, and modular system architectures to serve both diagnostic and interventional use cases. Strategic product roadmaps increasingly prioritize compatibility with telehealth and image-sharing platforms, enabling cross-site collaboration and remote consultation, while aftermarket services are being reframed as strategic levers to lock in long-term relationships through outcome-driven maintenance and clinician education.
New entrants and device innovators are focusing on niche differentiation, such as low-footprint handheld units optimized for primary care settings and advanced elastography-capable systems targeted at specialized breast centers. These entrants challenge incumbents to shorten development cycles and broaden service capabilities. Partnerships between device manufacturers and service providers that deliver integrated training, procedure-specific workflows, and rapid technical support are becoming decisive competitive factors. Finally, organizations that can demonstrate seamless integration into hospital information systems and clinical documentation workflows gain a distinct advantage among institutional buyers seeking to minimize disruption and maximize utilization of their imaging investments.
Practical strategies for product modularity, resilient supply chains, and service-driven commercial models to accelerate adoption and secure clinical value
Industry leaders should adopt a multi-pronged playbook that aligns product modularity with localized service excellence and flexible commercial models. Prioritize design choices that facilitate modular upgrades-allowing field-installable software improvements, probe compatibility, and accessory interchangeability-so that systems can adapt to evolving clinical protocols without requiring full capital replacement. Invest in structured training programs that pair simulated clinical scenarios with competency validation, thereby improving diagnostic consistency and accelerating time-to-value for buyers.
Strengthen supply chain resilience by diversifying component sources, identifying tariff exposure points, and formalizing contingency inventory strategies. In parallel, develop outcome-oriented service agreements that emphasize uptime, measured performance indicators, and rapid-response maintenance to reduce clinical disruption. Collaborate with clinical champions to document workflow advantages and to create reproducible protocols that demonstrate device value across diagnostic and interventional procedures. Finally, explore partnerships that enable integration with electronic health records and telemedicine platforms to support remote review and multisite workflows, increasing the stickiness of device deployments and enabling new reimbursement pathways for image-guided care.
A transparent and reproducible research approach combining literature synthesis, clinician interviews, and vendor engagement to surface actionable device and service insights
The research methodology combines systematic literature synthesis, structured expert interviews, and primary data capture from clinical stakeholders to deliver a holistic perspective on device usage, procurement behavior, and service expectations. Literature synthesis provides the technical and regulatory context for imaging modalities and transducer evolution, while interviews with radiologists, sonographers, procurement leaders, and biomedical engineers surface operational constraints, training needs, and decision criteria that are not always visible in published sources. This triangulation ensures that technical capabilities are assessed in light of real-world clinical workflows and institutional priorities.
Primary data collection focused on qualitative insights-such as decision-making rationales, perceived barriers to adoption, and the comparative value of service models-was complemented by vendor interviews to understand technology roadmaps and aftermarket strategies. The approach emphasized reproducibility and transparency: interview frameworks and data abstraction methods were standardized, and findings were synthesized through thematic analysis to identify convergent patterns. Where relevant, regulatory and tariff developments were analyzed through official documents and customs guidance to ensure accurate interpretation of operational implications. Together, these methods create a defensible foundation for the insights and recommendations presented throughout this executive summary.
Concluding synthesis emphasizing alignment of imaging performance, service continuity, and supply chain resilience as determinants of long-term clinical adoption
The synthesis underscores that the future of breast ultrasound will be determined by the degree to which technology, service, and supply chain innovations are aligned with clinical workflows and institutional objectives. Systems that prioritize image quality, probe ergonomics, and software flexibility will be more likely to be adopted across diagnostic and interventional settings, provided they are supported by rigorous training and robust service commitments. Tariff-induced supply chain complexity has elevated the importance of procurement sophistication and regional sourcing strategies, reinforcing the need for agile commercial models and contingency planning.
Importantly, adoption is not a straight function of feature lists; it is contingent on how easily a device can be integrated into existing pathways, how reliably it performs in high-volume environments, and how effectively vendors support clinicians in translating advanced imaging capabilities into better patient outcomes. Decision-makers should therefore evaluate offerings through a composite lens that weighs clinical applicability, service continuity, and operational resilience, ensuring that investments deliver sustained functional improvements for breast imaging and image-guided interventions.
Please Note: PDF & Excel + Online Access - 1 Year
An integrative orientation on breast ultrasound trends and clinical priorities designed to align device innovation with real-world diagnostic and interventional workflows
This executive summary synthesizes the current strategic dynamics and operational considerations shaping breast ultrasound across clinical, commercial, and supply chain domains. The report distills emerging technology trends, modality preferences, and user requirements that are influencing procurement choices and technology roadmaps in diagnostic and interventional care pathways. By concentrating on practical implications rather than projections, the analysis highlights how clinical workflows, device ergonomics, and service models are converging to elevate diagnostic confidence and procedural efficiency.
Stakeholders in clinical leadership, procurement, and product development will find a structured view of the evolving competitive ecosystem and the levers that affect adoption. The emphasis is on translating clinical need into device specification and on understanding how product portfolios of probes, systems, and consumables must adapt to changing practice patterns. The introductory narrative establishes the analytical lens for the remainder of the document: an operator- and patient-centric approach that aligns technology attributes with real-world clinical and operational constraints, enabling clearer priorities for investment and partnership.
How advances in imaging resolution, portable modalities, and service-driven commercial models are reshaping procurement priorities and clinical workflows in breast ultrasound
The breast imaging landscape is experiencing transformative shifts driven by a combination of technological maturation, workflow reconfiguration, and evolving clinical expectations. Advances in image resolution and elastography algorithms are enhancing lesion characterization capabilities, which in turn is changing how clinicians prioritize investments across systems, probes, and accessory suites. Simultaneously, the movement toward more portable and bedside diagnostics is accelerating the adoption of cart-based portable systems and handheld devices that can be integrated into outpatient clinics and ambulatory settings, reshaping traditional radiology-centric models.
Concurrently, service delivery models are shifting from pure transactional maintenance agreements toward outcome-oriented service partnerships that emphasize uptime, training, and remote diagnostics. Vendors that couple robust training programs with digital support and predictive maintenance features are gaining preference among health systems focused on continuity of care and operational efficiency. The combination of technological refinement and service innovation is therefore creating new competitive differentiation points tied to integration, ease of use, and the degree to which devices support multi-operator environments and interventional procedures.
Assessment of the 2025 US tariff adjustments and their operational consequences on sourcing, lead times, and procurement strategies for breast ultrasound ecosystems
Recent tariff measures instituted by the United States in 2025 have introduced new variables into supply chain planning and procurement for breast ultrasound equipment and accessories. Increased import duties on certain categories of medical equipment have prompted procurement teams to reassess supplier selection criteria, with emphasis placed on tariff classification expertise, alternative sourcing strategies, and the total landed cost of devices and consumables. These trade policy changes have also underscored the importance of contract flexibility, allowing buyers to negotiate terms that can mitigate sudden cost escalations and avoid disruptions to clinical operations.
Operationally, tariffs have lengthened lead times where manufacturers rely on cross-border components and finished goods, increasing the value of local inventory buffers and reinforcing partnerships with regional distributors. Manufacturers and providers have responded by intensifying efforts in tariff engineering-revising product bill of materials and HS code classifications where appropriate-and by expanding nearshoring and third-country sourcing options. The ripple effects extend to service and consumables, where items such as gel and sterile covers may be procured from different geographies to manage exposure. Ultimately, tariffs have elevated procurement sophistication and compelled both vendors and health systems to adopt a more proactive stance on trade compliance, supply redundancy, and scenario planning to sustain access to critical breast imaging capabilities.
Comprehensive segmentation analysis linking product types, modalities, technologies, transducer options, clinical applications, and end-user requirements to purchasing and adoption behaviors
Insight into segmentation reveals how product form, delivery modality, imaging technology, transducer design, clinical application, and end-user context each create distinct value propositions and adoption pathways. When the market is viewed by product, accessories and consumables such as gel and sterile covers represent recurring operational expenditures that must align with infection control protocols and operator ergonomics, while equipment encompassing probes and systems anchors capital planning and clinical capability. Services spanning installation, maintenance, and training are essential to ensure uptime and to translate advanced imaging features into reproducible clinical outcomes, and the interplay between these elements often dictates procurement cadence and vendor selection.
Considering modality, the differentiation between cart/trolley configurations and handheld formats informs deployment strategy: portable cart solutions, whether truly portable or trolley-mounted, are frequently chosen for centralized diagnostic suites, whereas battery-powered and tethered handheld devices enable point-of-care access in clinics and ambulatory surgical centers. Technology choices-ranging from 2D and 3D/4D ultrasound through Doppler and elastography-determine diagnostic scope and the types of clinical questions that can be addressed at the point of care, influencing both training needs and interpretation workflows. Transducer type matters for lesion accessibility and imaging fidelity; linear array, curved array, phased array, and emerging 3D transducers each offer trade-offs in field of view, resolution, and ergonomics, guiding procurement for specific clinical protocols.
From an application standpoint, diagnostic use cases such as lesion characterization, screening, and staging require consistent high-resolution imaging and reproducibility, while interventional tasks including aspiration, biopsy guidance, and drainage prioritize real-time visualization, probe handling, and sterile accessory compatibility. End-user considerations further refine segmentation: ambulatory surgical centers and clinics demand compact and easy-to-service systems with fast startup and minimal space footprint, diagnostic imaging centers emphasize multi-modality integration and advanced post-processing, and hospitals balance high-throughput scanning, diverse clinical teams, and comprehensive service agreements. The confluence of these segmentation dimensions underscores that a one-size-fits-all offering is unlikely to achieve broad adoption; instead, modularity, serviceability, and clinical fit are decisive.
Regional differentiation in adoption, regulatory context, and supply chain resilience shaping modality preferences and procurement strategies across global markets
Regional dynamics demonstrate distinct patterns of adoption, reimbursement influences, and supply chain strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, health systems and outpatient networks emphasize rapid integration of portable systems to expand access across decentralized care settings, and there is pronounced attention to purchasing practices that prioritize service continuity and interoperability with existing radiology workflows. In contrast, Europe, Middle East & Africa presents a heterogeneous set of adoption drivers, where regulatory harmonization in some subregions and resource variability in others shape differentiated demand for basic imaging functionality versus advanced features like elastography and 3D imaging.
Asia-Pacific exhibits strong demand for scalable, cost-efficient solutions that can serve high-volume screening programs as well as growing interventional capabilities in tertiary centers. Across all regions, local regulatory requirements, reimbursement mechanisms, and clinical pathway preferences influence the mix of systems, handheld devices, and consumables that are prioritized by buyers. Moreover, regional supply chain resilience considerations and the presence of local manufacturing capacity or distribution partners significantly affect lead times and service models, prompting stakeholders to design procurement strategies that balance local responsiveness with access to specialized technologies and training resources.
Competitive patterns driven by integration of advanced imaging features with service-led differentiation and interoperable technologies to secure clinical adoption and retention
Competitive dynamics in the breast ultrasound landscape are shaped by firms that combine imaging performance with comprehensive service and training offerings. Leading vendors are investing in software-defined imaging enhancements, probe ergonomics, and modular system architectures to serve both diagnostic and interventional use cases. Strategic product roadmaps increasingly prioritize compatibility with telehealth and image-sharing platforms, enabling cross-site collaboration and remote consultation, while aftermarket services are being reframed as strategic levers to lock in long-term relationships through outcome-driven maintenance and clinician education.
New entrants and device innovators are focusing on niche differentiation, such as low-footprint handheld units optimized for primary care settings and advanced elastography-capable systems targeted at specialized breast centers. These entrants challenge incumbents to shorten development cycles and broaden service capabilities. Partnerships between device manufacturers and service providers that deliver integrated training, procedure-specific workflows, and rapid technical support are becoming decisive competitive factors. Finally, organizations that can demonstrate seamless integration into hospital information systems and clinical documentation workflows gain a distinct advantage among institutional buyers seeking to minimize disruption and maximize utilization of their imaging investments.
Practical strategies for product modularity, resilient supply chains, and service-driven commercial models to accelerate adoption and secure clinical value
Industry leaders should adopt a multi-pronged playbook that aligns product modularity with localized service excellence and flexible commercial models. Prioritize design choices that facilitate modular upgrades-allowing field-installable software improvements, probe compatibility, and accessory interchangeability-so that systems can adapt to evolving clinical protocols without requiring full capital replacement. Invest in structured training programs that pair simulated clinical scenarios with competency validation, thereby improving diagnostic consistency and accelerating time-to-value for buyers.
Strengthen supply chain resilience by diversifying component sources, identifying tariff exposure points, and formalizing contingency inventory strategies. In parallel, develop outcome-oriented service agreements that emphasize uptime, measured performance indicators, and rapid-response maintenance to reduce clinical disruption. Collaborate with clinical champions to document workflow advantages and to create reproducible protocols that demonstrate device value across diagnostic and interventional procedures. Finally, explore partnerships that enable integration with electronic health records and telemedicine platforms to support remote review and multisite workflows, increasing the stickiness of device deployments and enabling new reimbursement pathways for image-guided care.
A transparent and reproducible research approach combining literature synthesis, clinician interviews, and vendor engagement to surface actionable device and service insights
The research methodology combines systematic literature synthesis, structured expert interviews, and primary data capture from clinical stakeholders to deliver a holistic perspective on device usage, procurement behavior, and service expectations. Literature synthesis provides the technical and regulatory context for imaging modalities and transducer evolution, while interviews with radiologists, sonographers, procurement leaders, and biomedical engineers surface operational constraints, training needs, and decision criteria that are not always visible in published sources. This triangulation ensures that technical capabilities are assessed in light of real-world clinical workflows and institutional priorities.
Primary data collection focused on qualitative insights-such as decision-making rationales, perceived barriers to adoption, and the comparative value of service models-was complemented by vendor interviews to understand technology roadmaps and aftermarket strategies. The approach emphasized reproducibility and transparency: interview frameworks and data abstraction methods were standardized, and findings were synthesized through thematic analysis to identify convergent patterns. Where relevant, regulatory and tariff developments were analyzed through official documents and customs guidance to ensure accurate interpretation of operational implications. Together, these methods create a defensible foundation for the insights and recommendations presented throughout this executive summary.
Concluding synthesis emphasizing alignment of imaging performance, service continuity, and supply chain resilience as determinants of long-term clinical adoption
The synthesis underscores that the future of breast ultrasound will be determined by the degree to which technology, service, and supply chain innovations are aligned with clinical workflows and institutional objectives. Systems that prioritize image quality, probe ergonomics, and software flexibility will be more likely to be adopted across diagnostic and interventional settings, provided they are supported by rigorous training and robust service commitments. Tariff-induced supply chain complexity has elevated the importance of procurement sophistication and regional sourcing strategies, reinforcing the need for agile commercial models and contingency planning.
Importantly, adoption is not a straight function of feature lists; it is contingent on how easily a device can be integrated into existing pathways, how reliably it performs in high-volume environments, and how effectively vendors support clinicians in translating advanced imaging capabilities into better patient outcomes. Decision-makers should therefore evaluate offerings through a composite lens that weighs clinical applicability, service continuity, and operational resilience, ensuring that investments deliver sustained functional improvements for breast imaging and image-guided interventions.
Please Note: PDF & Excel + Online Access - 1 Year
Table of Contents
192 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Adoption of contrast-enhanced ultrasound techniques to improve characterization of breast lesions
- 5.2. Rising utilization of automated breast ultrasound systems to enhance screening sensitivity in dense breast tissue
- 5.3. Advancements in elastography integrated into ultrasound devices for more accurate assessment of tissue stiffness in breast imaging
- 5.4. Increasing demand for portable and handheld breast ultrasound scanners for point-of-care diagnostics in outpatient settings
- 5.5. Development of AI-driven risk stratification tools combining clinical data with ultrasound imaging metrics for personalized breast cancer screening
- 5.6. Expansion of tele-ultrasound services enabling remote interpretation and collaboration among specialists for breast cancer diagnosis
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Breast Ultrasound Market, by Product
- 8.1. Accessories & Consumables
- 8.1.1. Gel
- 8.1.2. Sterile Covers
- 8.2. Equipment
- 8.2.1. Probes
- 8.2.2. Systems
- 8.3. Services
- 8.3.1. Installation
- 8.3.2. Maintenance
- 8.3.3. Training
- 9. Breast Ultrasound Market, by Modality
- 9.1. Cart/Trolley
- 9.1.1. Portable Cart
- 9.1.2. Trolley Mounted
- 9.2. Handheld
- 9.2.1. Battery Powered
- 9.2.2. Tethered
- 10. Breast Ultrasound Market, by Technology
- 10.1. 2D Ultrasound
- 10.2. 3D/4D Ultrasound
- 10.3. Doppler Ultrasound
- 10.4. Elastography
- 11. Breast Ultrasound Market, by Transducer Type
- 11.1. 3D Transducer
- 11.2. Curved Array
- 11.3. Linear Array
- 11.4. Phased Array
- 12. Breast Ultrasound Market, by Application
- 12.1. Diagnostic
- 12.1.1. Lesion Characterization
- 12.1.2. Screening
- 12.1.3. Staging
- 12.2. Interventional
- 12.2.1. Aspiration
- 12.2.2. Biopsy Guidance
- 12.2.3. Drainage
- 13. Breast Ultrasound Market, by End User
- 13.1. Ambulatory Surgical Centers
- 13.2. Clinics
- 13.3. Diagnostic Imaging Centers
- 13.4. Hospitals
- 14. Breast Ultrasound Market, by Region
- 14.1. Americas
- 14.1.1. North America
- 14.1.2. Latin America
- 14.2. Europe, Middle East & Africa
- 14.2.1. Europe
- 14.2.2. Middle East
- 14.2.3. Africa
- 14.3. Asia-Pacific
- 15. Breast Ultrasound Market, by Group
- 15.1. ASEAN
- 15.2. GCC
- 15.3. European Union
- 15.4. BRICS
- 15.5. G7
- 15.6. NATO
- 16. Breast Ultrasound Market, by Country
- 16.1. United States
- 16.2. Canada
- 16.3. Mexico
- 16.4. Brazil
- 16.5. United Kingdom
- 16.6. Germany
- 16.7. France
- 16.8. Russia
- 16.9. Italy
- 16.10. Spain
- 16.11. China
- 16.12. India
- 16.13. Japan
- 16.14. Australia
- 16.15. South Korea
- 17. Competitive Landscape
- 17.1. Market Share Analysis, 2024
- 17.2. FPNV Positioning Matrix, 2024
- 17.3. Competitive Analysis
- 17.3.1. Aurora Healthcare US Corp.
- 17.3.2. Braster S.A.
- 17.3.3. Canon Medical Systems Corporation
- 17.3.4. CapeRay Medical (Pty) Ltd.
- 17.3.5. Carestream Health, Inc. by Onex Corporation
- 17.3.6. Delphinus Medical Technologies, Inc.
- 17.3.7. Fujifilm Holdings Corporation
- 17.3.8. Fukuda Denshi Co., Ltd.
- 17.3.9. General Electric Company
- 17.3.10. Hitachi, Ltd.
- 17.3.11. Hologic, Inc.
- 17.3.12. Koninklijke Philips N.V.
- 17.3.13. QT Imaging, Inc.
- 17.3.14. QView Medical, Inc.
- 17.3.15. Samsung Electronics Co., Ltd.
- 17.3.16. Seno Medical Instruments, Inc.
- 17.3.17. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- 17.3.18. Siemens AG
- 17.3.19. SmartBreast Corporation
- 17.3.20. SonoCiné, Inc.
- 17.3.21. Trivitron Healthcare
- 17.3.22. Volpara Health Technologies Ltd.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
